ProKidney Stock (NASDAQ: PROK) stock price, news, charts, stock research, profile.
Open | $2.51 |
Close | $2.46 |
Volume / Avg. | 3.44M / 980.26K |
Day Range | 2.27 - 2.52 |
52 Wk Range | 1.12 - 13.51 |
Market Cap | $283.87M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 9.75% |
Days to Cover | 6.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ProKidney (NASDAQ:PROK) through any online brokerage.
Other companies in ProKidney’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Tectonic Therapeutic (NASDAQ:TECX), Renovaro (NASDAQ:RENB) and Zentalis Pharma (NASDAQ:ZNTL).
There is no analysis for ProKidney.
ProKidney has a consensus price target of $9.50.
The stock price for ProKidney (NASDAQ: PROK) is $2.46 last updated June 28, 2024 at 4:19 PM EDT.
There are no upcoming dividends for ProKidney.
ProKidney’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for ProKidney.
ProKidney is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.